🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Y‐Van Nguyen

University of North Carolina at Chapel Hill

ORCID: 0000-0003-1888-2147

Also affiliated with UNC Lineberger Comprehensive Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy”.

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy

Science Translational Medicine(2022)10.1126/scitranslmed.abq7019
N/A
0DataRank · unranked
55 citations

Nagendra Yarla, Tarek Haykal, Y‐Van Nguyen, Linda Cao, Michelle Ferreira +8 more

A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.26.538456
N/A
0DataRank · unranked
3 citations

Yue Xue, Y‐Van Nguyen, Nicholas C. DeVito, Xueying Wang, Alisha Holtzhausen +5 more

A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression

Science Immunology(2024)10.1126/sciimmunol.adi4191
N/A
0DataRank · unranked
126 citations

Yue Xue, Y‐Van Nguyen, Nicholas C. DeVito, X F Wang, Alisha Holtzhausen +4 more

Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin Signaling

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.31.587500
N/A
0DataRank · unranked
1 citations

Y‐Van Nguyen, Michael Sturdivant, Michael P. Plebanek, Kaylee Howell, Nagendra Yarla +6 more

Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Suppressing MHC Class I Expression

medRxiv(2025)10.1101/2025.10.06.25337175
N/A
0DataRank · unranked
0 citations

Nagendra Sastry Yarla, Kaylee Villareal, Y‐Van Nguyen, Linda Cao, Ernesto Pena Calderin +9 more